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Abstract
Despite explosive growth in genomic datasets, the methods for studying epigenomic mechanisms of gene regulation
remain primitive. Here we present a model-based approach to systematically analyze the epigenomic functions in
modulating transcription factor-DNA binding. Based on the first principles of statistical mechanics, this model considers the
interactions between epigenomic modifications and a cis-regulatory module, which contains multiple binding sites
arranged in any configurations. We compiled a comprehensive epigenomic dataset in mouse embryonic stem (mES) cells,
including DNA methylation (MeDIP-seq and MRE-seq), DNA hydroxymethylation (5-hmC-seq), and histone modifications
(ChIP-seq). We discovered correlations of transcription factors (TFs) for specific combinations of epigenomic modifications,
which we term epigenomic motifs. Epigenomic motifs explained why some TFs appeared to have different DNA binding
motifs derived from in vivo (ChIP-seq) and in vitro experiments. Theoretical analyses suggested that the epigenome can
modulate transcriptional noise and boost the cooperativity of weak TF binding sites. ChIP-seq data suggested that
epigenomic boost of binding affinities in weak TF binding sites can function in mES cells. We showed in theory that the
epigenome should suppress the TF binding differences on SNP-containing binding sites in two people. Using personal data,
we identified strong associations between H3K4me2/H3K9ac and the degree of personal differences in NFkB binding in
SNP-containing binding sites, which may explain why some SNPs introduce much smaller personal variations on TF binding
than other SNPs. In summary, this model presents a powerful approach to analyze the functions of epigenomic
modifications. This model was implemented into an open source program APEG (Affinity Prediction by Epigenome and
Genome, http://systemsbio.ucsd.edu/apeg).
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Introduction
Central to transcriptional regulation of gene expression is the
regulation of the quantities of transcription factors (TF) bound to
genomic regulatory sequences. The information used to quanti-
tatively control TF-DNA binding is not only encoded in the
genomic sequences, but likely is also embedded in the chemical
modifications to the genomic sequences and the nearby histones
[1]. The chemical modifications (called epigenomic modifications)
include the addition of a methyl group or a hydroxymethyl group
to the 5th carbon of cytosine (5-mC and 5-hmC) and a number of
posttranslational modifications to the histone proteins [2]. These
modifications can alter the chromatin structure and function by
changing the charge of the nucleosome or directly interacting with
TFs [3]. In turn, TFs can tether DNA modification enzymes and
histone modification enzymes to change the epigenomic modifi-
cations around the TF binding region. Hence, both the genomic
sequences and the epigenetic modifications contribute to define
the regional diversity of the regulatory genome. Less clear is how
the genome and the epigenome jointly encode regulatory
information, and how TFs interact with such regulatory informa-
tion. The goal of this work is to model the three-way interactions
among the TFs, the genomic sequence, and the epigenome, and
thus allowing for predicting TF binding affinities in equilibrium
states.
Genome-wide distributions of TF-binding and epigenomic
modifications can now be obtained by high-throughput sequenc-
ing methods [4]. The explosive growth of data urges the
methodological developments that can achieve mechanistic
understanding of gene regulation. In particular, quantitative
models are needed to learn the regulatory rules implemented by
epigenomic modifications. Two classes of methods were developed
to study transcriptional regulation with different goals and
mathematical foundations. The first class of methods aims at
deriving regulator-target relationships or finding regulatory
sequences and motifs. These methods were built upon statistical
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associations among sequence patterns, TF binding, and gene
expression [5–11]. An advantage of this class of methods is that it
is easy to incorporate new data types including epigenomic
modifications. Indeed, using statistical enrichment and machine
learning ideas, recent efforts have incorporated nucleosome
positions [12] and epigenomic modifications to identify TFBSs
[13] and regulatory genomic sequences [12,14–18] (Table S1B).
However, machine learning methods do not allow direct
biophysical interpretation for their parameters, and therefore they
do not make biological inferences as directly as the thermody-
namic models (see below).
The second class of methods aims at deriving molecular
mechanisms of TF-DNA interactions, using a thermodynamic
framework (reviewed in [19]). The intensity of TF-DNA binding
was modeled as the equilibrium output of input sequences and TFs
[20,21]. Partially due to a huge computational burden, this class of
methods was originally restricted to analyze a few selected
regulatory sequences in single-cell organisms, where a few simplified
assumptions can be made [20–22] (Model assumptions, Table S1A).
These models were extended to analyze nucleosome positions
[23,24], gene expression in drosophila embryonic development [25–
27], and genome-wide TF binding data [28]. The latter develop-
ment offered a unique advantage, which is the capability of gaining
mechanistic understanding of TF-TF interaction and TF-DNA
binding from genome-wide binding data. However, this class of
models cannot easily take into account epigenomic modifications,
which are argued to be more influential to TF-DNA binding than
cooperative interactions between TFs [29,30]. Here we present a
thermodynamic model that incorporates epigenomic modifications.
This model can learn synergistic and antagonistic interactions
between specific TFs and epigenomic modifications from genome-
wide TF binding and epigenomic data.
We were interested in a few open questions on the mechanisms
of TF-DNA binding. First, to what extent does an epigenetic
modification change the binding strength between a TF and a
genomic sequence, which is composed of multiple strong and weak
binding sites? Second, is the epigenomic influence to TF-DNA
binding invariant to the nucleotide composition of the genomic
sequence? Third, many TFs have preferred DNA recognition
codes (a.k.a. motifs); are there TF-specific epigenomic recognition
codes? Fourth, does the epigenome modulate the variability (noise)
of gene expression in an isogenic cell population? Finally, what is
the role of the epigenome in modulating individual variation of
TF-binding among humans?
We used two complementary experimental systems to study the
above questions. The first system is mouse embryonic stem (mES)
cells. We recently assayed genome-wide distributions of 5-
methylcytosine (5-mC), 5-hydroxymethylcytosine (5-hmC), histone
variant H2A.Z, and acetylation of histone 3 lysine 27 (H3K27ac)
[31]. We combined these data with published chromatin
immunoprecipitation followed by sequencing (ChIP-seq) datasets
of 5 other epigenomic modifications [2,32,33] and 9 TFs [34] from
mES cells. This combined dataset allowed us to study TF-
epigenome-DNA interactions relatively comprehensively. The
second system is the white blood cells of seven people, which
allowed us to explore individual differences in humans.
Results
An epigenome-sensitive TF-DNA binding model
We developed a quantitative model for TF-DNA binding in a
given epigenomic context. The goal of this model is to predict the
binding intensity of a TF in any genomic region in any cell type,
using the genomic sequence and the epigenomic modifications
(cell-type-specific data). This model incorporates four types of
biophysical information: the active concentrations of the TFs
(learned from ChIP-seq data), the binding preferences of these TFs
to DNA (motif), the nucleotide composition of the genomic
sequence, and the epigenomic modifications (see Methods). Given
input data including position-specific weight matrices (PSWM),
ChIP-seq derived TF binding sequences and binding intensities,
and genome-wide distribution of epigenomic modifications, this
model can learn cooperativity among TFBSs (any number of
strong and weak, homotypic and heterotypic TFBSs). More
importantly, it can learn synergistic and antagonistic interactions
between a specific TF and every assayed epigenomic modification.
The learning process involves two steps (Figure 1B). First, the
model scans each epigenomic mark independently to identify those
that interact with the transcription factor of the interest and
modulate its binding affinities to genomic sequences. Second, these
identified epigenomic marks are combined into one unified model
to predict the binding affinity of any genomic regions. The model
quantifies the improvements of predicted binding affinities by
using the identified epigenomic marks (Table S2). Because this
model operates at thermodynamic equilibrium, it does not make
causal inferences about epigenetic and TF binding changes. We
implemented this model into an open source program APEG
(Affinity Prediction by Epigenome and Genome, http://
systemsbio.ucsd.edu/apeg).
Genome-wide distributions of 5-methylcytosine, 5-
hydroxymethylcytosine, H2A.Z, and H3K27ac in mES cells
We recently published two types of 5-methylcytosine (5-mC)
data in E14 mES cells, using methylated DNA immunoprecipi-
tation followed by sequencing (MeDIP-seq) and DNA digestion by
methyl-sensitive restriction enzymes followed by sequencing
(MRE-seq) [31,35]. A total of 45.2 million reads were generated
from MeDIP-seq, reflecting 1,495,114 methylated 200 bp geno-
mic segments (windows) across the genome (Text S1). A total of
2.1 million MRE-seq reads were generated from a total of three
restriction enzymes, covering 428,367 unmethylated windows. We
used a selective chemical labeling method to pull down and
sequence 5-hydroxymethylcytosine (5-hmC) regions (5-hmC-seq)
[31,36]. A total of 58 million 5-hmC-seq sequence reads were
Author Summary
We developed a model-based approach to systematically
analyze the epigenomic functions in modulating transcrip-
tion factor-DNA binding. We postulated the existence of
TF-specific epigenomic motifs, which could explain why
some TFs appeared to have different DNA binding motifs
derived from in vivo and in vitro experiments. The
theoretical results suggested that the epigenome can
modulate transcriptional noise and boost the cooperativity
of weak TF binding sites. A preliminary analysis of the
existing data suggested that epigenomic boost of binding
affinities in weak TF binding sites could be a widespread
regulatory mechanism in mES cells. Moreover, using
personal data, we identified strong associations between
H3K4me2/H3K9ac and the degree of individual differences
in NFkB binding in SNP-containing binding sites, suggest-
ing the theoretical mechanism for epigenome to attenuate
the TF binding differences on SNP-containing binding sites
in two individuals may contribute to link genomic variation
to phenotypic variation. Thus, this model presents a
powerful approach to analyze the functions of epigenomic
modifications.
Modeling TF-Epigenome-Genome Interactions
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generated, detecting 1.5 million 5-hmC marked windows in mES
cells. We assayed the genomic distribution of histone variant
H2A.Z and acetylation of Histone 3 Lysine 27 (H3K27ac) in E14
mES cells [31]. With 19.9 million ChIP-seq reads, 1.1 million
200 bp windows were found to contain H2A.Z. It has a small
overlap with promoter regions (10.45% of H2A.Z marked
windows), suggesting its substantial involvement in distal regula-
tory regions [37–39]. With a total of 19.8 million ChIP-seq reads,
around 1.0 million 200 bp windows were marked by H3K27ac. It
had a moderate overlap with promoter regions (16.66%), in line
with the thought that it is primarily an enhancer mark [40].
Interestingly, H2A.Z and H3K27ac exhibited differential overlaps
with 5-hmC marked windows (25.69% and 31.57%) and 5-mC
marked windows (17.69% and 12.98%), respectively. This suggests
both H2A.Z and H3K27ac tend to overlap with 5-hmC more than
with 5-mC (both p-values,2.2e-16, Chi-square test). Combining
these data with 6 published ChIP-seq datasets [2,32,33], we
obtained genome-wide distributions of 9 epigenetic marks and 9
transcription factors in mES cells, which served as the dataset for
our model-based analyses.
Identification of TF-specific epigenomic motifs
Even though some epigenomic modifications are assumed to
take some general roles in synergizing or antagonizing TF-DNA
binding, little is known whether such epigenomic functions are
specific to certain TFs or are general to every TF. To explore this
question, we applied our new model to genome-wide distribution
data of 9 TFs and 9 types of epigenomic modifications in mES
cells (assayed by ChIP-seq, MeDIP-seq, MRE-seq, and 5-hmC-
seq). Thirty interactions between TFs and epigenomic modifica-
tions were identified, forming an interaction network (Figure 2A,
Table S2). Here, ‘‘interaction’’ refers to the positive or negative
correlation of an epigenetic modification and the binding between
a TF and DNA. Among the 9 epigenetic modifications,
H3K4me3, H3K27ac, and 5-mC each interacts with a large
number of TFs, forming hubs in the interaction network. Among
the five epigenetic modifications that exhibited negative roles, only
5-mC represses the mES cell-specific regulators Oct4, Sox2,
Nanog, and Stat3. Compared to the hubs, H3K4me1 is more
specific. It plays a positive role to the binding of Nanog, Sox2 and
Stat3. Even more specific are H2A.Z, 5-hmC, and H3K9me3,
which may negatively correlate with the binding of cMyc and
nMyc. These data suggest that not all epigenomic modifications
‘‘uniformly’’ interact with every TF. Some epigenetic modifica-
tions may be associated with the binding of specific TFs.
Considering TFs often have recognition preferences to certain
short genomic sequences (motifs), we hypothesized that there are
TF-specific epigenomic motifs. By an epigenomic motif we refer to
Figure 1. Modeling the epigenome and the genome as a physical system. (A) The states of the system and their probabilities. As an
example, a hypothetical genomic sequence is occupied by two epigenomic modifications (orange and gray shades), which partially overlap. The
sequence contains three TFBSs for two TFs (A and B). The two TFBSs for A (red boxes) are each occupied by one epigenomic modification, and the
TFBS for B (green box) is located in the overlapping region of the two modifications. The first TFBS for A (red box on the left) and the TFBS for B are
close enough for their bound TFs to interact (arrows in States 5 and 8). Because each of the three TFBSs can reside in either the bound or the
unbound state, the whole sequence can reside in a total of 23 physical states (listed in the State column). c: a physical state; W(c): Boltzmann weight
for state c, which is proportional to the probability that the system visits this state; qepi: the binding affinity between a transcription factor and the
sequence under the epigenomic context. (B) The workflow for inferring epigenetic marks that influence the binding of a TF. Central to this workflow
is our epigenome-sensitive TF-DNA binding model (the Epigenetic biophysical model). Inputs to this model are TF binding data (ChIP-seq), PSWM of
the TF and epigenomic modification data (ChIP-seq, 5-hmC-seq, MeDIP-seq, and MRE-seq). Outputs of the model include the influences of
epigenomic marks to the binding of each transcription factor and the cooperativities between TFBSs.
doi:10.1371/journal.pcbi.1003367.g001
Modeling TF-Epigenome-Genome Interactions
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a specific combination of epigenetic modifications that is
characteristic to the in vivo binding sites of a TF. To test this
hypothesis, we estimated the association of every epigenetic
modification and the binding of each TF, i.e. vAk in Equation
(5). For each TF, we compiled the influences of epigenetic
modifications as a column vector (Figure 2B). These influences are
not identical across TFs (columns of Figure 2B). This suggests that
analogous to DNA motifs, in vivo TF-DNA binding also have
epigenomic motifs. A PSWM is used to describe DNA motifs [41].
We propose to use the vector of model-learned influences of the K
epigenetic marks {vA1 , …, v
A
k } to describe TF-specific epigenomic
motifs, where A denotes the TF of our interest and K represents
the total number of epigenetic marks. The epigenomic motifs can
be used in combination with PSWMs to approximate the binding
preferences of transcription factors in vivo.
Epigenomic motif improves predictions of TF binding
intensities
We hypothesized that the predictive power of TF binding
intensities should be increased by incorporating the information of
epigenomic motifs. In other words, if epigenomic motifs exist, they
should help to better predict TF binding intensities than using
DNA sequences alone. Three computational experiments were
done to test this hypothesis. We chose the Nanog TF for these
experiments, mostly because Nanog is an essential TF in ES cells
and Nanog’s DNA recognition motif is not well understood. In the
first experiment, we removed the epigenomic data and fed our
model with genomic sequences only. Without epigenomic data,
our model degenerates into the STAP model [28]. STAP uses the
sequences (500 bp) and the TF-specific PSWM to predict TF
binding affinities, taking into account all possible interactions
among strong and weak TFBSs. To quantify the model’s
predictive power, we used the Pearson correlation between the
ChIP-seq signals (as observed binding intensities) and the model-
predicted binding intensities. Pearson correlations were 0.211 and
0.212 in the training and the testing datasets, respectively,
providing a baseline predictive power (Control-1 in red,
Figure 3). We then applied the model to test each epigenomic
modification. H3K4me1, H3K27ac and H3K4me3 largely
increased the model’s predictive power of Nanog binding
intensities from the baseline (red bars, Figure 3). These three
epigenomic marks were thus inferred as interacting with Nanog.
To test the robustness of model inference, we changed the metric
for quantifying prediction power into Spearman’s rank correlation
(Figure S1) and varied window sizes (Figure S2). Neither of these
changes affected the inferred interacting epigenomic marks.
In the second experiment, we randomly shuffled the genomic
positions of the observed epigenetic modification intensities,
generating 200 permutated datasets. Feeding the permutated
datasets to the model, we obtained a background distribution of
predictive power (Control-2 in red, Figure 3). Using this
background distribution, we identified three epigenetic modifica-
tions with which the model can significantly better predict TF
binding intensities (red bars with * in Figure 3, permutation p-
value = 0). These three epigenetic modifications were identified as
interacting with Nanog. This permutation experiment used the
same number of model parameters and the same amount of data
(PSWM, sequence, and epigenetic data) as the experiment using
the original data. It rules out the possibility that the increased
predictive power was due to increased model complexities.
TF-specific epigenomic motif is cell-type specific
As the 3rd control experiment, we replaced the epigenetic
modifications in mES cells with the epigenetic modifications of
mouse adipose cells [42] and kept the other data intact. None of
the four epigenetic modifications in mouse adipose cells signifi-
cantly increased the predictive power of Nanog binding in mES
cells (green bars vs. Control-1 and Control-2 in red, Figure 3),
suggesting our learned TFBS-epigenomic interactions were cell-
type specific.
Figure 2. Transcription factor-specific epigenomic codes. (A) An interaction network between TFs (orange nodes) and epigenetic
modifications (blue nodes) in mES cells (p-value cutoff = 0.05). The interactions include positive (red edges) and negative correlations (green edges) of
TF binding and epigenetic marks. This network suggests that each TF has its specific epigenetic marks for interaction. (B) TF-specific epigenomic
motifs. The influences of every epigenetic mark to the binding of a TF (vAk in Equation (5)) are summarized as a column vector. In analogy to matrix
presentation of DNA recognition motifs, we propose to use a column vector to represent the epigenomic motif of a TF. Each column represents an
epigenomic motif {vA1 , …, v
A
k }, and the first column is {v
cMyc
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Epigenome alone is less predictive of TF binding than
epigenome and genome combined
We asked to what extent the epigenome can predict TF binding
without using the genomic sequences. Two control datasets were
generated. First, each epigenomic mark was fed to our model
without sequence data (Si becomes invariant to i in Equation (4),
solid red bars, Figure S3). The enhancer and open chromatin
marks H3K4me1 and H3K27ac were most strongly predictive of
Nanog binding, followed by the promoter mark H3K4me3. These
data are consistent with the idea that open chromatin and
hypersensitivity sites are predictive of transcription factor binding
regions [18]. Interestingly, H2A.Z is the fourth epigenomic mark
that is predictive of Nanog binding. The regulatory function of
H2A.Z in mammalian cells remains controversial. While H2A.Z is
generally thought as an active mark of transcription, it is negatively
correlated with gene expression in a mES cell differentiation
process [43]. The positive association of H2A.Z with Nanog
binding suggests that H2A.Z may facilitate Nanog binding in
undifferentiated mES cells. Second, we collected all (214) PSWMs
from the JASPAR database as background motifs [44]. These
background PSWMs were fed to the model with each epigenomic
mark. The mean and standard deviation of the model predicted
binding intensities from these background PSWMs were derived
(hollow red bars and error bars, Figure S3). The predictive powers
of these control datasets were compared to the predictive powers
using both epigenomic and PSWM information (blue bars, Figure
S3). The in vivo Nanog motif combined with epigenomic data (solid
blue bars) increased the accuracy of predicted Nanog binding
affinities than using epigenomic data alone (red bars). More than
20% increases of predictive power were observed using Nanog
motif and H3K4me1 or H3K27ac than using H3K4me1 or
H3K27ac alone. Even larger increases were found in comparing in
vivo Nanog motif (solid blue bars) with background PSWMs
(hollow red bars). The latter comparison used models with the
same number of model parameters. It rules out the possibility that
the increased predictive power was due to increased model
complexities.
In vitro derived TF-DNA binding motifs do not interact
with epigenomic motif
The TF-DNA binding motifs derived from the enriched
sequence patterns using in vitro binding assays do not always agree
with the enriched motifs from in vivo binding assays [45].
Depending on the TFs, the differences in motifs derived from in
vitro and in vivo experiments can be small [46] or large [28]. The
causes of such differences are unknown. We hypothesized that
some epigenomic modifications can synergize with DNA to
produce a somewhat different binding preference of a TF than
Figure 3. Epigenomic marks improve model predictions of Nanog binding. Model predicted binding intensities are correlated to ChIP-seq
reported binding intensities (y axis: Pearson correlation). The model predictions are based on sequence data alone (Control-1), sequence data plus
randomized epigenomic data (Control-2), or sequence data plus one epigenomic mark (other columns). Results on both training data (shaded bars)
and testing data (hollow bars) are plotted. Epigenomic marks that significantly improve the predictions of Nanog binding (marked by *) are identified
by using the standard deviations of the control experiments (error bars). Combined with the Nanog motif (PSWM) derived from in vivo experiments
(red bars), several epigenomic marks can increase the accuracy of predicted binding intensities, achieving Pearson Correlations above 0.47 (H3K4me3
and H3K27ac, red bars). However, combined with the Nanog motif derived from in vitro experiments (blue bars), no epigenetic mark except H3K27ac
can improve the predictions of ChIP-seq measurements. Even for H3K27ac, the Pearson Correlation obtained from the in vitro motif (0.29) is much
smaller than the Pearson correlation obtained from the in vivo motif (0.47). None of the four measured epigenomic marks in adipose cells help to
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the binding preference of this TF to naked DNA. To test this
hypothesis, we chose to further analyze the Nanog motifs derived
in vitro [47] and in vivo [28]. We used the in vitro Nanog motif
together with all epigenomic data to learn and predict in vivo
binding affinities (blue bars, Figure 3) and compared to the results
from the in vivo motif (red bars, Figure 3). Without considering
epigenomic data, the in vitro and in vivo motifs had similar
predictive powers of ChIP-seq signals (Control-1 in red vs.
Figure 4. Epigenomic regulation of transcriptional noise. Transcriptional noise is introduced when the binding probability (y axis) between a
TF and its target TFBS falls into a particular range (horizontal yellow band). There is nearly no noise above or below this range, because almost all cells
would uniformly have this target TFBS in the bound or the unbound state, respectively. The binding probabilities are constrained by the realistic
range (vertical blue band) of TF concentrations in eukaryotic cells (x axis). (A) In the presence of a strong binding site (S), the binding probabilities are
shown as functions of the TF concentration and the presence of epigenomic marks (Red curve: activation mark, green: no epigenomic marks, blue:
repression mark). Activation marks suppress transcriptional noise by reducing the range of feasible binding probabilities, whereas repression marks
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Control-1 in blue, Figure 3). However, except for H3K27ac,
adding epigenetic modifications to the in vitro motif did not
increase the predictive power of Nanog binding. Even for
H3K27ac, its contribution to predicting Nanog binding was much
larger when combined with the in vivo motif than when combined
with the in vitro motif (red and blue H3K27ac bars, Figure 3). This
means the model failed to identify clear TFBS-epigenomic
interactions with the in vitro Nanog motif, suggesting that the
epigenomic motif is specific to the in vivo Nanog DNA binding
motif. In several cases, including H3K4me3, H3K27me3,
H3K36me3, and 5-mC (both MRE and MeDIP), feeding the
model with epigenetic data together with the in vitro motif even
slightly decreased its predictive power as compared to not using
epigenetic data at all (blue bars vs. Control-1 in blue, Figure 3).
This is because the model allowing for TFBS-epigenomic
interactions is more complex than that without epigenetic data.
However, there is no extra information added due to the lack of
interaction between the in vitro motif and the epigenetic marks.
These data explain the difference between the TF-DNA binding
motifs derived in vivo and in vitro: although the Nanog sequence
motifs derived in vitro and in vivo have similar binding affinities to
the Nanog protein in vitro [28], the in vivo motif predicted Nanog
binding events with a higher sensitivity given the specificity (Figure
S4). This suggests that only the in vivo motif may interact with
epigenetic modifications. The in vivo binding intensities are
determined by TFBS-epigenomic interactions and cannot be
faithfully reproduced with the sequence motif (either in vitro or in
vivo) alone.
Epigenomic regulation of transcriptional noise
We asked how epigenomic modifications may theoretically
modulate transcriptional noise [48] and the cooperativity of
TFBSs. To address this question, we used constraint-based
simulation studies [49], with the constraints being the physical
and empirical limits of TF concentrations and epigenomic states in
eukaryotic cells (Text S1).
Transcriptional noise is the variability of gene expression among
cells in an isogenic population [48,50,51]. We asked whether the
epigenome can modulate the level of transcriptional noise. We
studied simple transcription systems with one TFBS, by examining
the change in binding probability as a function of the concentra-
tion of the TF and the presence of epigenomic marks. Following
the main assumption of thermodynamic models of gene expres-
sion, every cell in an isogenic cell population has the same
probability of producing a transcript, denoted as p (p~c|PA(O),
where PA(O) is defined in Equation (1) and c is a constant). The
expected number of transcripts is proportional to p, therefore the
variability of p reflects transcriptional noise [23].
Without any epigenomic marks, the binding probability
increased as the concentration of the TF increased, forming a
sigmoid curve (green curve, Figure 4A–B). In a transcriptional
system with one strong TFBS, the binding probability should
reach the half of the maximum binding probability when the TF
concentration passes a low threshold [52]. With a weak TFBS, the
half of maximum binding probability should be reached at a high
threshold of the TF concentration. Because the range of TF
concentrations is generally between 10,000 and 300,000 molecules
per cell in fruit fly, mouse, and human cells (reviewed by [29]), in
our simulation of a strong TFBS, the half of the maximum binding
probability was reached when the TF concentration reached
10,000 molecules per cell (green curve, Figure 4A). In the other
simulated system containing a weak TFBS, the half of the
maximum binding was reached at the TF concentration of
300,000 molecules per cell (green curve, Figure 4B).
In the presence of an activation mark, the sigmoid curve of
binding probabilities shifted to the left (red curve, Figure 4A–B)
with no overlap to the original curve. Similarly, in the presence of
a repression mark, the curve shifted to the right (blue curve,
Figure 4A–B). The dynamic range of TF binding probabilities,
constrained by the range of TF concentrations, is a major
indicator of transcriptional noise [23]. These constraint-based
simulations provided a theoretical prediction that in the presence
of a strong binding site, an activation mark decreases the dynamic
range of binding probabilities and thus suppresses transcriptional
noise, whereas a repression mark enhances transcriptional noise
(Figure 4A). However, in a transcriptional system with a single
weak binding site, both activation and repression marks tend to
suppress transcriptional noise (Figure 4B). The key assumption to
these predictions is that the half of total binding probability of a
weak (strong) TFBS is reached at about the upper (lower) bound of
the available concentrations of the TF.
The epigenome may boost the cooperativity of weak
binding sites
We asked whether the epigenome could modulate the
cooperativity of adjacent TFBSs. To obtain a baseline (no
cooperativity) for this analysis, in a simulation study, we fixed
the TF concentration ( [A] in Equation (4)) and compared the
binding affinities between a strong TFBS and a weak TFBS in
various epigenomic conditions. As expected, in the presence of an
activation mark, the binding affinity increases as the intensity of
this activation modification increases (solid curves, Figure 5A), and
the reverse is true in the presence of a repression mark (dashed
curves, Figure 5A). Moreover, an increase of epigenomic intensity
produces a smaller difference in the binding affinities of the two
TFBSs (solid and dashed curves become closer as epigenomic
intensity increases, Figure 5A). However, the binding affinity of a
weak TFBS cannot surpass the affinity of a strong TFBS in any
levels of an epigenomic modification (neither the solid curves nor
the dashed curves crossed, Figure 5A). In other words, when there
is no cooperativity between TFBSs, under the same epigenomic
condition, the order of binding strengths among different genomic
sequences is fixed. Because TF concentration ([A]) is a multipli-
cative factor that is separate from the rest in the calculation of the
binding affinity (q
epi
i in Equation (4)), changing TF concentration
would not change the contributions from other factors to the
binding affinity (q
epi
i ). Thus, the analyses above hold for any TF
concentrations.
Next, we examined the cooperativity of adjacent TFBSs with
simulations. With nearly no epigenomic modifications, a simulated
genomic sequence containing two weak TFBSs exhibited a
binding affinity larger than that of another sequence containing
one weak TFBS (dashed and solid blue curves at epigenomic
intensity = 1022, Figure 5B), but smaller than that of a medium-
strength TFBS and a strong TFBS (green and red curves at
epigenomic intensity = 1022, Figure 5B). As the intensity of an
activation mark increased, the binding affinity of the two-weak-
TFBS sequence first surpassed that of the medium-strength TFBS
and later superseded the strong TFBS to become the sequence
with the largest binding strength (Figure 5B). This suggests that in
the presence of the epigenome, the binding affinities of different
genomic sequences may not always be monotonic. Considering
that without cooperativity, the binding affinities of different
sequences are strictly monotonic (Figure 5A), these data suggest
that epigenomic modifications are not only capable of increasing
the binding affinity of each of the two weak TFBSs, but also can
increase the cooperativity between the two TFBSs.
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Figure 5. Epigenomic boost of cooperativity of weak binding sites. (A) The relationship between binding probability and epigenetic
intensity. Given the transcription factor concentration, the binding probability (y axis) is shown as functions of the intensities (Epigenetic intensity, x
axis) and types (solid: activation, dashed: repression) of epigenomic modifications and the strengths of the binding sites (red: strong, blue: weak). For
a single binding site, the binding probability is monotonic to the strength of the binding site for all intensities of epigenomic modifications (red
curves are always above blue curves). (B) Epigenomic boost of binding-site cooperativity. In the presence of an activation mark, the binding
probabilities are monotonic for single strong (red), medium-strength (green), and weak (blue) binding sites. A pair of two weak binding sites has a
smaller binding probability in the absence of the activation mark (dotted blue line at Epigenetic intensity = 1022). While the intensity of the activation
mark increases, the binding probability of this pair of weak sites gradually surpasses that of the medium-strength site and the strong binding site,
breaking the monotonicity of single binding sites. (C) Activation mark H3K4me3 has larger average intensities in weak-TFBS regions (blue) than in
strong-TFBS-containing regions (red). SD: standard deviation. (D) The difference of model-predicted binding probabilities with and without the
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Finally, we examined whether the binding affinity of the two
weak TFBSs could surpass that of the medium-strength TFBS
within the range of typical intensities of epigenomic modifications
measured by ChIP-seq experiments. The dashed curve and the
green curve crossed at the epigenomic intensity of 100.12 ( = 1.32),
corresponding to the enrichment ratio of e1.32 ( = 3.74) between
the number of sequence reads in the input and the control
samples. Because the enrichment ratio of these two numbers is
typically between 1 and 40 [53], the change of order of the binding
affinities of these two simulated genomic sequences can happen in
typical epigenomic conditions.
Epigenomic boost of weak TFBSs is potentially a
regulatory mechanism
With the theoretical understanding that epigenomic modifica-
tions can boost the cooperativity of weak TFBSs, we hypothesized
that this is a general mechanism of quantitative regulation of gene
expression. We explored this hypothesis with tri-methylation of
Histone 3 Lysine 4 (H3K4me3) and the transcription factor Oct4,
which is essential for maintaining undifferentiation [54,55] of mES
cells (Text S1). Using Oct4 PSWM, we scanned all Oct4 binding
regions, which were defined by the peaks in ChIP-seq data in mES
cells [33]. We categorized the Oct4 TFBSs into two sets, strong
TFBSs (2055 regions, Text S1) and weak TFBSs (1921 regions).
The average H3K4me3 intensity on weak-TFBSs was larger than
150% of that on strong-TFBSs (p-value,10220, Figure 5C). The
largest difference of H3K4me3 intensities between the two sets
appeared at the center of Oct4 binding regions (Position= 0,
Figure 5C). This suggests that on Oct4 binding regions throughout
the genome, H3K4me3 is more concentrated on those containing
only weak sequence motifs. We ruled out promoters as a
confounding factor to the association of strong H3K4me3 to
weak TFBSs, because weak TFBSs do not preferentially locate in
promoters (Chi-square test p-value = 0.907, Table S3, Text S1).
We then asked if these weak-TFBS-only sequences could obtain
a larger boost of binding affinity than the other sequences. Our
simulation analysis suggested this was the case in theory
(Figure 5B). We now test it with the measured epigenomic and
TF binding intensities in mES cells. We classified the ChIP-seq
peaks into three sets, those only containing strong TFBSs, those
containing both strong and weak TFBSs (mixed), and those only
containing weak TFBSs. We computed the change in Oct4
binding affinities on these sequence sets from not using H3K4me3
ChIP-seq data to using H3K4me3 ChIP-seq data. The weak-
TFBS-only set exhibited a larger increase in binding affinities than
the mixed set, which in turn had a larger increase than the strong-
TFBS-only set (Figures 5D, S5). These data suggest that the
endogenous levels of H3K4me3 in mES cells are sufficient to boost
the binding affinity of adjacent weak TFBSs.
Finally, had epigenomic boost of weak TFBSs happened in vivo,
the model would be able to better reproduce in vivo binding
intensities on weak TFBSs. To test this idea, we used DNA
sequence and H3K4me3 to predict Oct4 binding regions and
compared with ChIP-seq data. We quantified the improvements of
the prediction accuracy between with and without considering
H3K4me3 data. Applying the model with a stringent threshold on
the predicted binding probability, the three sequence groups that
harbor strong, mixed, and weak sites showed similar improve-
ments on prediction accuracy (strong-cutoff, Figure 5E). This
indicates H3K4me3 helps to improve prediction, but does not
specifically show it helps prediction on weak sites. Under two less
stringent thresholds of the predicted binding probabilities, the
model gained larger increases of prediction accuracy on weak sites
and on mixed sites than on strong sites (Medium-cutoff, Weak-
cutoff, Figure 5E). These results are consistent with the idea that
the model was able to predict the binding intensities more
accurately by capturing the epigenomic boost of weak TFBSs.
Besides H3K4me3 and Oct4, several other epigenomic marks
showed systematically stronger intensities near the weak TFBSs
than near the strong TFBSs of other TFs (Table S4). Thus,
epigenomic boost of the binding affinity of adjacent weak TFBSs is
not only a theoretical possibility, but also can be a wide-spread
regulatory mechanism.
H3K9ac and H3K4me2 may dampen the variation of TF
binding across human individuals
Genomic variations including single nucleotide polymorphisms
(SNPs) can result in phenotypic variation. Still unknown is how
epigenomes modulate the correlation of genotypes and phenotypes
among humans. We chose TF binding intensities as a molecular
phenotype to study this question.
To study how epigenetic variation can interact with genomic
variation, we did three between-individual comparisons across
different ethnic groups. We first compared a European (NIGMS
catalog ID: GM12878) and a Nigerian (GM18505). We catego-
rized NFkB binding regions with the TFBSs containing SNPs into
two sets (all analyses were done with homozygous SNPs, Text S1).
The first set had differences in NFkB binding intensities between
these two individuals. This set was called Different Sequence
Different Binding (DSDB) (Figure S6A). The second SNP-
containing set had similar NFkB binding levels in the two
individuals, and were termed the Different Sequence No
Difference in Binding (DSNDB) set. The first set (DSDB) was
consistent with the theory that nucleotide changes in the TFBS
should change the binding affinity of this TFBS; however, the
second set (DSNDB) appeared to be inconsistent with such a
theory. We hypothesized that the epigenetic marks on DSNDB
stabilized the binding affinities of these binding sites. In other
words, the epigenetic modifications on the TFBSs buffered
sequence changes (SNPs) from changing binding intensities.
Theoretically, the difference in binding affinities between two
TFBSs is the largest without any epigenetic marks (y-intercept,
Figure 5A). When epigenetic modification intensities increase, the
binding difference in the two TFBSs decreases (from left to right,
Figure 5A). This is true for any two TFBSs of the same TF. Thus,
we have derived a theoretical mechanism for the epigenome to
attenuate the TF binding differences on SNP-containing TFBSs in
two individuals.
epigenome (y axis) is larger in weak-TFBS-only regions (right column) than in the regions containing both strong and weak sites (mixed, middle
column), which in turn is larger than in the strong-TFBS-only regions (left column). (E) H3K4me3 enables larger improvements of prediction accuracy
on regions containing weak TFBSs. The predictions of binding for these regions were determined by applying three cutoffs on the predicted binding
probability calculated from the model (Weak-cutoff (0.3), Medium-cutoff (0.35), Strong-cutoff (0.4)). The improvement of prediction accuracy was
quantified by comparing the predictions by sequence and H3K4me3 to the predictions by sequence only (Y-axis). The improvement was defined as
the difference of the proportions of correctly predicted binding regions between using and not using H3K4me3 data. Red, purple, and green bars
represent the sequences that contain strong, weak, and mixed TFBSs as determined by PSWM matching scores. Error bars: standard deviations. The
number of each type of sequences is in parenthesis.
doi:10.1371/journal.pcbi.1003367.g005
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We proceeded to examine whether the theoretical mechanism is
relevant for transcription factor binding in humans. We first used
our model to learn epigenetic marks that help to explain the
binding intensities in all SNP-containing TFBSs (Table S5). Four
epigenetic marks were identified by the model, which were
H3K4me1/2, H3K9ac, and H3K27ac (Figure S7). Among them,
H3K4me2 and H3K9ac were identified as marks that better
explain the binding intensities in DSNDB sites. If H3K4me2 and
H3K9ac were used to attenuate binding differences between two
people, there should be higher intensities of H3K4me2 and
H3K9ac in DSNDB sites than in DSDB sites. Indeed, the
intensities of H3K4me2 and H3K9ac were much higher in
DSNDB sites than in DSDB sites (p-values,10220, Figure 6). To
assess whether these results were specific to the chosen individuals
in our analysis, we did two more comparisons. The second
comparison was between a European (GM12878) and a Nigerian
(GM19099), and the third comparison was between a European
descendant (GM12878) and a Japanese (GM18951). Each
comparison identified its own DSDB and DSNDB sites. However,
all comparisons found significantly higher H3K4me2 and H3K9ac
intensities in DSNDB sites than in DSDB sites (Figure S8). The
NFkB binding intensities in DSDB and DSNDB of GM12878 had
similar distributions, and therefore are unlikely to contribute to
explain the differences of H3K4me2 and H3K9ac intensities in
GM12878 (Figure S6B–C). As a control, adding H3K36me3 data
to the model did not increase the correlation of model predicted
binding intensities to NFkB ChIP-seq data (Figure S7). Accord-
ingly, the difference in H3K36me3 levels between DSDB and
DSNDB sets was not clear and not consistent in these comparisons
(Figure S8). Finally, we assessed whether inter-individual differ-
ences of PSWM matching scores were significantly different in
DSDB and DSNDB regions. No significant differences were found
in two pairs of individuals (Figure S9, S10), ruling out the
possibility that sequence-determined differences in binding ener-
gies were more pronounced in either of the two sequence sets.
These data suggested a mechanistic explanation to the SNPs in
TFBSs that do not produce between-individual differences in TF
binding: epigenetic modifications on these TFBSs attenuated the
binding differences. We note that not all factors relevant to gene
regulation have been considered in this analysis. Other factors
including DNase sensitivity and the binding of other TFs could
play a role in buffering polymorphism in NFkB binding sites and
therefore potential provide alternative explanations.
Discussion
The overarching tenet of this work is obtaining mechanistic
insights from high-throughput genomic data. Towards this goal,
we forfeited commonly used ‘‘statistical enrichment’’ methods that
look for large overlaps of two or more genomic features. Instead,
we developed a biophysical model for the three-way interactions
among the genomic sequence, the epigenetic modifications, and
TF binding. The model is specified as a physical system, and every
model parameter has a biophysical interpretation. This allows the
analytical results obtained from this model to have mechanistic
interpretations.
Several epigenetic modifications were previously assumed to
facilitate or hinder TF binding in a ubiquitous manner. For
example, mono-, di-, and tri- methylations on histone lysine 4
(H3K4me1/2/3) were thought to facilitate the binding of any TF.
Our data suggested that some TFs tend to preferentially recognize
TF-specific epigenomic codes. This implies that rather than
ubiquitously synergize or antagonizing TF-DNA binding, some
epigenetic marks can specifically interact with some TFs. This is
conceivable because the maintenance of epigenetic marks often
require histone or DNA modification enzymes to be brought to a
genomic sequence by specific transcription factors [56,57]. In
addition, epigenetic modifications are strongly associated with the
three-dimensional (3D) architectures of the local chromatin [58]. It
is also conceivable that some TFs would have different binding
preferences to the same DNA sequence but different 3D
chromatin conformations. We showed that epigenetic modifica-
tions can boost the cooperativity of adjacent weak TFBSs. Thus,
there is a functional advantage of coding a cis-regulatory sequence
with a cluster of weak TFBSs rather than one strong binding site.
The advantage is that the binding affinity of a cluster of weak
TFBSs has a larger tunable range than a strong TFBS, in the
presence of the epigenome. Thus, clusters of weak TFBSs offer the
epigenome larger ‘controllability’. This may explain why weak
TFBSs tend to cluster in the mammalian genomes [59].
Figure 6. H3K9ac and H3K4me2 dampen personal variation of NFkB binding. The average intensities of H3K9ac and H3K4me2 are higher in
DSNDB regions (blue) than in DSDB regions (red). The centers of all NFkB ChIP-seq peaks are superimposed to ‘Position 0’ on the x axis. DSNDB:
different sequence no difference in binding. DSDB: different sequence different binding. SD: standard deviation.
doi:10.1371/journal.pcbi.1003367.g006
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Consistently, we estimated that there were 2.3–4.6 weak Oct4 sites
per ChIP-seq derived Oct4 binding region. Indeed, H3K4me3
was strongly enriched in Oct4 binding regions that only contained
weak TFBSs. Moreover, H3K4me3 generated larger enhance-
ments of binding affinities in the weak-TFBS-only binding regions
than in other Oct4 binding regions. Thus, the ‘epigenomic boost’
of TFBS cooperativity can be a functional mechanism in
mammalian cells. This provides an alternative view on the
evolutionary origin of TFBS clusters, in which the presence of
the epigenome was previously ignored [60].
A central question in personalized medicine is how genomic
variation generates phenotypic variation. This is a challenging
question because genomic variation was only partially correlated
with TF-binding variation [61]. In particular, a set of SNPs in
TFBSs does not introduce differences to TF binding as predicted
by available TF-DNA binding models. Incorporating the epigen-
ome into the TF-DNA binding model, we can now appreciate that
some epigenetic marks can buffer genomic changes from
generating changes in TF binding intensities. A case in point is
that H3K4me2 and H3K9ac attenuate the personal variation of
NFkB binding on SNP-containing binding sites in human
lymphocytes. These results highlight the importance of considering
the epigenome when analyzing the functional consequences of
genomic variations.
A limitation of the thermodynamic equilibrium model is that it
does not make causal inferences. It does not differentiate whether
an epigenomic motif promotes the binding of a TF, or the binding
of a TF causes the buildup of an epigenomic motif. It is
conceivable that TF binding and epigenomic motif can reinforce
each other, in a sequence-dependent or sequence-independent
manner. Recent cross-species comparisons reported larger evolu-
tionary changes of TF binding regions [62] than epigenetically
modified regions [43]. If we assume during evolution we should
see larger changes in the effects than in the causes, then these data
are compatible to the hypothesis that epigenetic factors could
modulate the binding of specific TFs. Moreover, the model-
identified epigenomic mark that have strong interaction with Oct4
binding is H3K4me3, whose intensity is much larger in the Oct4
binding regions that contain only weak TFBSs than in the binding
regions that contain strong TFBSs (Figure 5C). If Oct4 binding
had been the cause of H3K4 tri-methylation, we would expect
H3K4me3 to be stronger on the regions containing strong Oct4
sites. Thus, at least in the case of Oct4 and H3K4me3 interaction,
the data disfavor TF binding as the cause of this interaction.
Methods
Model assumptions
First, a DNA sequence is associated with a physical state, which
is defined by the combination of transcription factors bound to the
sequence. When we consider one piece of genomic sequence a
time, the physical state of a sequence can be regarded as the
physical state of a cell. Second, TF-DNA binding has reached
thermodynamic equilibrium, which implies the proportion of cells
at each physical state does not change over time. Third, the
binding affinity between a TF to any genomic location is a joint
effect of multiple TFBSs in the ‘‘neighborhood’’ of this genomic
location. Each TFBS has its own binding strength, and they may
cooperate. Finally, the intensity of an epigenomic modification in
this genomic neighborhood can influence TF binding.
Model formulation
We model a genomic sequence (S) in a fixed epigenomic context
as a physical system. Every TFBS in S can exist in one of the two
physical states, occupied or not occupied by a TF. Thus, a
sequence containing n TFBSs can exist in any of the total of 2n
states (Figure 1A shows the 23 states for a sequence containing 3
TFBSs). We use c to denote a state, and let C to denote all states.
There is certain probability associated with every state of the
system, denoted as P(c). Such a probabilistic distribution is called a
Boltzmann distribution [21].
From the perspective of a particular TF (named A), the event
that A is bound to sequence S is equivalent to the union of some of
states of S. In the example in Figure 1, the event ‘A is bound’ is the
union of States 2, 4, 5, 6, 7, and 8. We call these states the occupied
states (O). Obviously, C~OzO. The probability that A is bound




. We introduce the Boltzmann weight,
W (c), for every state c. W (c) is proportional to P(c) in the way
that P(c)~W (c)=
P
c[C W (c). Thus, the probability that A is






We model the Boltzmann weight W (c) as follows. Two factors
contribute to W (c). The first factor is the binding affinity between
the TF (A) and every TFBS, which is jointly determined by the
TFBS and the epigenomic context. We denote this factor as qepi.
The second factor is the cooperativity between TFBSs, denoted as






where i and j are the indices of the TFBSs on S; and oi is the
indicator of whether the ith TFBS is occupied (oi~1, if occupied;
oi~0, otherwise). This formulation implies that the state with no
TFBSs bound (oi~0 for every i) has a Boltzmann weight of 1
(State 1 in Figure 1A). Suppose the ith and the jth TFBSs are







We then model the binding affinity (q
epi
i ) between TF A and the
ith TFBS (denoted by Si). Three factors can contribute: the TF
concentration ([A]), the preference of the TF to bind onto the
binding site sequence Si (denoted as K(Si)), and the epigenomic
influence (vAepi(Si)). These are modeled as
q
epi
i ~½A:K(Si):vAepi(Si)~½A:K(Si):Pk vAk (Si), ð4Þ
where k is an index for each type of epigenomic modification. Here
K(Si) is the association constant of the binding site Si. We note that
K(Si)~K(Scon)e
{DE(Si ), where Scon is the consensus binding site
and DE(Si) is the extra energy needed to bind onto a non-
consensus sequence, which is correlated with the usual matching
score between a TFBS (Si) and the PSWM of the TF. v
A
k (Si)
represents the influence of the kth epigenomic modification on the
binding intensity on Si.
We model the TFBS-specific epigenomic influence vAk (Si) as
follows. Let vAk be the overall effect of the k
th epigenomic
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modification to transcription factor A,
vAk
w1, epigenomic modification k promotes binding
~1, no influence
v1, epigenomic modification k suppresses binding
8><
>: ð5Þ
The TFBS-specific effect vAk (Si) is a joint effect of the overall
effect (vAk (S)) and the intensity of the k
th epigenomic modification
on Si (denoted as Ik(Si)). Taking the ChIP-seq data for a histone
modification for example, Ik(Si) is measured by the ratio of the
number of sequencing reads between the experimental sample and
the control sample. This study used the number of extended
sequencing reads (Text S1) falling on Si. We model the joint effect as
vAk (Si)~
(vAk )




where s is a threshold determining whether the measured intensity
is beyond noise level. We note thatvAk (Si)~1 implies either there is
no detectable kth modification or the kth modification has no
influence to the binding. Figure 1A illustrates how this model works
for a sequence with three TFBSs and two partially overlapping
epigenomic modifications. We call this model an epigenome-
sensitive TF-DNA binding model.
Making inferences with the model
This model has two major applications. One is to predict the
binding intensities of a TF throughout the genome in any cell type.
The other application is to learn genomic-location-specific
epigenomic influences on TF binding, i.e. vAk (Si). A third and
relatively minor application is to learn the cooperativity between
TFBSs in different epigenomic contexts. The required inputs are
the genome sequence, the PSWM of the TF, and the epigenomic
data. Epigenomic data are often generated by ChIP-seq, MeDIP-
seq, and other sequencing based experiments. Standard analysis
packages, including sequence mapping [63] and mapped reads
postprocessing [42] can process each dataset into a genome-wide
distribution of the intensity of an epigenomic modification. Our
model takes such a distribution as an input through Ik(Si), the
intensity of the kth epigenomic modification on Si.
Statistical learning with the model
The model has two sets of models parameters, which are the
cooperativity between TFBSs (vA,B) and the influence of each
epigenomic modification (vAk ). To train these model parameters,
four inputs are required. These include the genome sequence, the
PSWM of the TF, the epigenomic data (ChIP-seq and other
forms), and the ChIP-seq data of the TF of interest. Let I(A) be the
genome-wide distribution of binding intensities of transcription
factor A. For example, if we segregate the human genome into 6
million 500 bp long windows, then I(A) is a vector of 6 million
elements. Each element represents the ChIP-seq measured binding
intensity in the corresponding window. Following previous
notations, we use PA(O) in equation (1) to denote the model
predicted binding probability of A in every window. We propose
to learn the model parameters by maximizing the following target
function
f (vAk ,vA,B)~corr(PA(O),I(A)), ð7Þ
where corr(.) is the Pearson Correlation, and PA(O) is a function of
vAk and vA,B.
Computational strategy
We implemented a maximization strategy to maximize f(vAk ,
vA,B). The analytical form of P(A) can be explicitly expressed with
a dynamic programming algorithm [28]. We maximize it by the
Quasi-Newton Method (a.k.a. BFGS algorithm) provided in the
GNU Scientific Library [25,64]. We start with random initial
parameters and repeat it 500 times to avoid local minima. In
applications where the cooperativity among TFBSs is not of
interest, we propose to ignore the cooperativity term (set vA,B=1)
and only maximize with respect to vAk .
Identification of TF-specific epigenomic interactions
We identify an epigenomic modification k as associated with the
binding of TF A when vAk&1 (positive) or vAk%1 (negative). To
test for the null hypothesis that vAk =1, we shuffle the intensities of
epigenomic modification k on the genome to obtain 200 random
epigenomic profiles. We subsequently compute 200 vAk values
from the shuffled data and use them as the empirical null
distribution. For each epigenomic modification k, we test vAk =1
using the empirical null distribution and reject the null hypothesis
using a multiple-hypothesis-adjusted p-value [65] (Figure 1B).
Supporting Information
Figure S1 Comparison of different metrics of predic-
tion power.Model predicted binding intensities are correlated to
ChIP-seq reported binding intensities (y axis). The model
predictions were based on sequence data alone (Control-1),
sequence data plus randomized epigenomic data (Control-2), or
sequence data plus one epigenomic mark (other columns). Results
on training data (shaded bars) and testing data (hollow bars) using
Spearman correlation (red bars) and Pearson correlation (blue
bars) are plotted. The model inferred influence of each epigenomic
mark to Nanog binding (vA~Nanogk in Equation (5)) is given in the
brackets following each mark.
(EPS)
Figure S2 Comparison of window sizes on model
predictions. Model predicted binding intensities are correlated
to ChIP-seq reported binding intensities (y axis). The model
predictions were based on sequence data alone (Control-1),
sequence data plus randomized epigenomic data (Control-2), or
sequence data plus one epigenomic mark (other columns). Results
on training data (shaded bars) and testing data (hollow bars) with
the window sizes of 350 bp (red bars) and 500 bp (blue bars) are
plotted. The model inferred influence of each epigenomic mark to
Nanog binding (vA~Nanogk in Equation (5)) is given in the brackets
following each mark.
(EPS)
Figure S3 Comparing model predictions with different
sequence motifs. Using the Nanog dataset, we compared model
predictions in four scenarios. In each scenario, the model
predictions were correlated to ChIP-seq measured Nanog binding
intensities (y axis). These scenarios are: 1, simple correlation
between epigenomic data and binding data without using the
model (solid pink bars); 2, using each epigenomic mark with all the
(214) PSWMs from the JASPAR database (hollow pink bars: the
mean of the 214 correlations, error bar: standard deviation of the
mean); 3, using each epigenomic modification with the in vivo
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Nanog motif (solid blue bars); 4, using each epigenomic
modification with the in vitro Nanog motif (hollow blue bars).
(EPS)
Figure S4 Differences of the predicted TF binding
regions from the in vivo and the in vitro Nanog motifs.
The in vivo and in vitro motifs with epigenetic data (Here
H3K4me1 as an example) were used to predict TF binding regions
(BRs). The prediction based on the model returning a binding
probability score within [0, 1], and the TF BRs were called by
applying a threshold on this probability score. The numbers of TF
BRs were called with a high threshold (A, B) and a low threshold
(C, D) in both training data (A, C) and testing data (B, D). The
numbers of true positive TF BRs (verified by ChIP-seq) are given
outside of the parentheses. The total numbers of predicted TF
BRs, including both true positives and true negatives are given
inside the parentheses.
(EPS)
Figure S5 Comparison of different cutoffs on calling
strong and weak binding sites. The difference of model-
predicted binding probabilities with and without the epigenome (y
axis) is larger in weak-TFBS-only regions (right column) than in
the regions containing both strong and weak sites (mixed, middle
column), which in turn is larger than in the strong-TFBS-only
regions (left column). The thresholds for calling strong sites and
weak sites are K(Scon) – 3.5 and K(Scon) – 7.0, respectively, where
K(Scon) is the consensus score. These thresholds are different from
those used in Figure 5D.
(EPS)
Figure S6 Variations of the strengths of NFkB binding
regions. (A) The inter-individual variation of the strengths of
NFkB binding regions are quantified by Difference Ratio ( DR, y
axis), which is defined as DR=|I(Si) - I(Sj)|/min( I(Si), I(Sj)), where
I(Si) and I(Sj) are the binding strengths of sequences Si and Sj in
individuals i and j measured by ChIP-seq experiments. The mean
(each bar) and standard error (error bars) of DRs in DSDB (left)
and DSNDB sequence sets (right) are shown. The distribution of
GM12878 NFkB binding in DSDB (left) and DSNDB (right)
sequence sets, where DSDB and DSNDB were identified from the
comparison of GM12878 and GM18505 (B) and from the
comparison of GM12878 and GM12892 (C). CEU: Northern
and western Europe. YRI: Nigeria. SE: standard error.
(EPS)
Figure S7 Interactions of NFkB and epigenomic marks.
The Pearson correlation between model-predicted and ChIP-seq
measured binding intensities (x axis) is used to identify the
epigenomic marks interacting with NFkB. The genomic sequence
and ChIP-seq data of GM12878 were used to fit the model. DSDB
and DSNDB sequences were identified from comparing sequence
and epigenomic data of GM12878 and GM18505. The results
from four-fold cross validations are shown. Shaded bars: training
data. Hollow bars: testing data. Length of each bar: the average
value from four-fold cross validations. A total of 200 randomized
epi- datasets were used as controls (Control). Four-fold cross
validations were performed on each randomized dataset. The
mean correlation from these four-fold cross validations of 200
random datasets is represented by the length of each Control bar.
Error bars: standard deviations of the mean. The epigenomic
marks that significantly increase the Pearson correlation from the
control experiments are identified (*, p-value,0.01).
(EPS)
Figure S8 H3K9ac and H3K4me2 are associated with
small variation of NFkB binding. Two other comparisons
(GM12878 vs. GM19099 and GM12878 vs. GM18951) confirm
that the average intensities of H3K9ac and H3K4me2 are higher
in DSNDB regions (blue) than in DSDB regions (red). As a control,
no reproducible differences between DSNDB and DSDB regions
are found for H3K36me3. The centers of all NFkB ChIP-seq
peaks are superimposed to ‘Position 0’ on the x axis. DSNDB:
different sequence no difference in binding. DSDB: different
sequence different binding. SD: standard deviation. CEU:
Northern and western Europe. YRI: Nigeria. JPT: Japan.
(EPS)
Figure S9 Variations of binding energies of the TFBSs
with SNPs. (A)The inter-individual variation of the TFBS
binding energies was determined by PSWM scores. For individuals
i and j with a SNP in a NFkB binding region Sk, the absolute
difference of sequence-determined binding energies is defined as
|ei(Sk) – ej(Sk)|, where ei(Sk) and ej(Sk) are the PSWM scores of
TFBS sequence Sk in individuals i and j. The mean (each bar) and
standard error (error bar) in CEU (left) and CEUYRI (right) are
shown. The distribution of variations of binding energies in (B)
CEU and (C) CEUYRI comparison.
(PDF)
Figure S10 Distribution of PSWM matching scores in
DSDB and DSNDB regions. (A) CEU (B) CEUYRI compar-
ison.
(PDF)
Table S1 (A) Biophysical models of TF-DNA binding. (B)
Machine learning models to incorporate epigenomic information
on TF binding.
(DOCX)
Table S2 Comparison of model performances with and
without epigenomic data. Transcription factor binding and
epigenomic data in mES cells were used as inputs. Model-inferred
interacting epigenomic marks of each transcription factor (row) are
reported (2nd column). Model performances were evaluated with
Pearson correlation using both sequence data and epigenomic
data (3rd column) and using sequence data alone (4th column). The
improvement was quantified as the difference of the correlations
divided by the correlation without epigenomic data (5th column).
vAk : the overall effect of the k
th epigenomic modification to
transcription factor A, as defined in Equation (5).
(DOCX)
Table S3 Lack of association between weak TFBSs and
promoters. The distribution of strong and weak TFBSs in
promoters and other regions are summarized. Chi-square test p-
value = 0.907.
(DOCX)
Table S4 Epigenomic marks with greater intensities
near weak TFBS. For each TF (row) and each epigenomic mark
(column), we tested whether the ChIP-seq signals of this
epigenomic mark were significantly different near weak TFBSs
than those near strong TFBSs. Significant differences of
epigenomic intensities were marked with ‘‘v’’.
(DOCX)
Table S5 Distribution of SNP-containing NFkB binding
sites. The numbers of NFkB binding sites that contain
polymorphic nucleotides between two individuals are summarized.
Depending on whether these polymorphic nucleotides generated
differences in NFkB binding intensities, these SNP-containing
binding sites are separately counted. DSDB: Different Sequence
Different Binding. DSNDB: Different Sequence No Difference in
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Binding. CEU: A person from northern or western Europe. YRI:
A person from Nigeria.
(DOCX)
Text S1 Supplementary methods.
(DOCX)
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